United Kingdom Infection Diagnostics Market Insight
Published: 22 June 2026 | Report Format: Electronic (PDF) | Author: Komal and Radhika
United Kingdom Infection Diagnostics Market is projected to grow at a CAGR of around 8.4%, driven by increasing prevalence of infectious diseases, rising demand for rapid diagnostic testing and disease surveillance programs.
United Kingdom Infection Diagnostics Market Forecasts to 2035
- The United Kingdom Infection Diagnostics Market size was estimated at approximately USD 1.4 Billion in 2025.
- The market is expected to grow at a CAGR of around 8.4% from 2025 to 2035.
- The United Kingdom Infection Diagnostics Market is projected to reach approximately USD 3.1 Billion by 2035.
Notable Insight the United Kingdom Infection Diagnostics Market
- Based on product type segmentation, Molecular Diagnostics accounts for nearly 46% of market revenue in 2025, supported by increasing adoption of PCR-based and nucleic acid amplification technologies for accurate pathogen detection.
- Based on test type segmentation, Laboratory-Based Diagnostics represents approximately 61% of total market demand, driven by high testing volumes, advanced laboratory infrastructure, and clinical accuracy requirements.
- The market is increasingly influenced by rapid point-of-care testing technologies, with infectious disease screening and monitoring applications accounting for more than 57% of diagnostic procedures performed in 2025.
Download the eBook (ToC)
- Growing investments in public health surveillance, antimicrobial resistance monitoring, and outbreak preparedness are supporting market expansion, with molecular and rapid diagnostic platforms accounting for nearly 44% of new diagnostic system installations in 2025.
What Makes Decisions Advisors Research Unique?
- Intelligent Market Research Based on AI for Semiconductors & Optoelectronics
Decisions Advisors offers intelligent market research which includes advanced analysis of infrared sensor technologies, optoelectronic semiconductors, AI-driven sensing solutions, and remote sensing. Our research identifies potential areas of business development, technology adoption rates, competitive position analysis, and important strategic changes in South Korea Remote Sensing Infrared Light Emitting Diode Market.
- Highly Effective Research Approaches with Accurate Forecast Analysis
The research process uses advanced methodologies such as primary research interview approaches, industry research, tracking the semiconductor value chain, and data triangulation to deliver accurate market sizing, CAGR forecasting, investment analysis, and technology forecasting. The study examines the demand for semiconductor solutions in automotive electronics, industrial automation, health care monitoring, and smart surveillance applications in South Korea.
- Highly Competitive Environment Analysis
In-depth analysis of key infrared LED players, optoelectronic semiconductor innovations, AI-enabled sensing solutions, product launch activities, and collaborations is included in the report. The report also covers semiconductor regulations, technology research and development analysis, smart sensor infrastructure, and new opportunities available in the South Korea Remote Sensing Infrared Light Emitting Diode Market.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Infection Diagnostics Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies United Kingdom Infection Diagnostics Market
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- bioMérieux SA
- Danaher Corporation (Cepheid)
- Becton, Dickinson and Company (BD)
- QIAGEN N.V.
- Hologic, Inc.
- Sysmex Corporation
Recent Developments:
- In March 2025, diagnostic companies introduced next-generation multiplex molecular testing platforms capable of simultaneously detecting multiple infectious pathogens with enhanced accuracy and faster turnaround times.
- In February 2025, healthcare providers expanded point-of-care infectious disease testing capabilities to improve early diagnosis, treatment decisions, and outbreak management across hospitals and community healthcare settings.
Market Segmentation:
United Kingdom Infection Diagnostics Market, By Product Type
- Molecular Diagnostics
- Immunodiagnostics
- Clinical Microbiology
- Point-of-Care Diagnostics
- Rapid Diagnostic Tests
United Kingdom Infection Diagnostics Market, By Infection Type
- Respiratory Infections
- Bloodstream Infections
- Gastrointestinal Infections
- Sexually Transmitted Infections (STIs)
- Hospital-Acquired Infections
United Kingdom Infection Diagnostics Market, By End User
- Hospitals
- Diagnostic Laboratories
- Clinics
- Academic & Research Institutes
Expert Views:
The United Kingdom Infection Diagnostics Market is expected to witness robust growth through 2035, supported by increasing infectious disease burden, growing demand for early and accurate diagnosis, and rising adoption of molecular and point-of-care diagnostic technologies. Advancements in genomics, AI-enabled diagnostics, rapid testing platforms, and healthcare digitalization are anticipated to strengthen the long-term growth prospects of the market across clinical, laboratory, and public health applications.
Author: Komal and Radhika By Decisions Advisors and Consulting